Title | Type | SJR | H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2000) | %Female (2000) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 11.816 Q1 | 254 | 23 | 57 | 7959 | 1370 | 57 | 25.67 | 346.04 | 17.81 | |
2 | Cell Chemical Biology | journal | 4.089 Q1 | 206 | 122 | 353 | 4930 | 2082 | 324 | 5.57 | 40.41 | 25.79 | |
3 | Molecular Pharmacology | journal | 2.904 Q1 | 210 | 341 | 833 | 12293 | 4887 | 833 | 5.85 | 36.05 | 31.70 | |
4 | Folding and Design | journal | 2.526 Q1 | 62 | 0 | 121 | 0 | 554 | 117 | 5.07 | 0.00 | 0.00 | |
5 | Molecular Medicine | journal | 2.285 Q1 | 133 | 86 | 221 | 1697 | 905 | 216 | 3.61 | 19.73 | 33.17 | |
6 | Human Gene Therapy | journal | 2.126 Q1 | 159 | 208 | 729 | 8546 | 4721 | 710 | 6.13 | 41.09 | 29.38 | |
7 | Journal of Medicinal Chemistry | journal | 1.794 Q1 | 301 | 532 | 1618 | 22146 | 7004 | 1549 | 4.30 | 41.63 | 28.45 | |
8 | Pharmacogenetics and Genomics | journal | 1.688 Q1 | 152 | 89 | 232 | 3279 | 1182 | 229 | 4.62 | 36.84 | 27.11 | |
9 | Journal of Pharmacology and Experimental Therapeutics | journal | 1.502 Q1 | 244 | 605 | 2162 | 22444 | 8285 | 2162 | 3.64 | 37.10 | 30.51 | |
10 | Nucleic Acid Therapeutics | journal | 1.372 Q1 | 77 | 49 | 197 | 1700 | 646 | 194 | 2.82 | 34.69 | 28.90 | |
11 | Blood Cells, Molecules, and Diseases | journal | 1.341 Q1 | 98 | 69 | 136 | 2126 | 427 | 130 | 2.95 | 30.81 | 44.41 | |
12 | Medicinal Research Reviews | journal | 1.338 Q2 | 150 | 22 | 71 | 2038 | 266 | 70 | 3.35 | 92.64 | 20.83 | |
13 | Journal of Natural Products | journal | 1.306 Q2 | 161 | 429 | 1161 | 6997 | 2072 | 1160 | 1.85 | 16.31 | 29.37 | |
14 | Pharmaceutical Research | journal | 1.067 Q2 | 229 | 235 | 902 | 5810 | 2367 | 869 | 2.50 | 24.72 | 27.36 | |
15 | Stem Cells | journal | 1.054 Q2 | 253 | 74 | 280 | 2676 | 633 | 275 | 1.89 | 36.16 | 29.00 | |
16 | OMICS A Journal of Integrative Biology | journal | 0.985 Q2 | 69 | 22 | 53 | 684 | 69 | 51 | 1.63 | 31.09 | 27.87 | |
17 | BioFactors | journal | 0.787 Q2 | 113 | 140 | 225 | 2418 | 421 | 220 | 1.75 | 17.27 | 23.33 | |
18 | Journal of Biomolecular Screening | journal | 0.754 Q2 | 86 | 49 | 111 | 721 | 215 | 99 | 2.22 | 14.71 | 26.47 | |
19 | Nuclear Medicine and Biology | journal | 0.641 Q3 | 98 | 123 | 360 | 3549 | 632 | 357 | 1.80 | 28.85 | 21.86 | |
20 | Journal of Gene Medicine | journal | 0.638 Q3 | 100 | 53 | 54 | 2263 | 118 | 54 | 2.19 | 42.70 | 32.53 | |
21 | Vascular Pharmacology | journal | 0.520 Q3 | 108 | 94 | 689 | 3057 | 926 | 686 | 1.25 | 32.52 | 35.41 | |
22 | Viral Immunology | journal | 0.501 Q3 | 70 | 53 | 82 | 1898 | 105 | 82 | 1.12 | 35.81 | 32.57 | |
23 | Journal of Biochemical and Molecular Toxicology | journal | 0.433 Q3 | 69 | 44 | 85 | 576 | 107 | 85 | 1.26 | 13.09 | 31.45 | |
24 | Biotechnology and Applied Biochemistry | journal | 0.431 Q3 | 81 | 60 | 200 | 2001 | 248 | 193 | 1.30 | 33.35 | 37.79 | |
25 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.397 Q3 | 53 | 144 | 1028 | 3802 | 697 | 1028 | 0.64 | 26.40 | 32.49 | |
26 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.328 Q4 | 40 | 75 | 352 | 2504 | 275 | 352 | 0.53 | 33.39 | 22.76 | |
27 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.120 Q4 | 29 | 0 | 24 | 0 | 4 | 22 | 0.17 | 0.00 | 0.00 | |
28 | Molecular Therapy | journal | 209 | 170 | 0 | 5838 | 0 | 0 | 0.00 | 34.34 | 28.47 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®